CA2088927A1 - Mecanisme de conservation de la vitamine e en solution aqueuse - Google Patents

Mecanisme de conservation de la vitamine e en solution aqueuse

Info

Publication number
CA2088927A1
CA2088927A1 CA 2088927 CA2088927A CA2088927A1 CA 2088927 A1 CA2088927 A1 CA 2088927A1 CA 2088927 CA2088927 CA 2088927 CA 2088927 A CA2088927 A CA 2088927A CA 2088927 A1 CA2088927 A1 CA 2088927A1
Authority
CA
Canada
Prior art keywords
tpgs
formulation
range
citric acid
sodium citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2088927
Other languages
English (en)
Inventor
Donald Skeffington
Hansruedi Siegrist
Adom Boudjikanian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ciba Geigy Canada Ltd
Original Assignee
Ciba Geigy Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Canada Ltd filed Critical Ciba Geigy Canada Ltd
Priority to CA 2088927 priority Critical patent/CA2088927A1/fr
Publication of CA2088927A1 publication Critical patent/CA2088927A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
CA 2088927 1993-02-11 1993-02-11 Mecanisme de conservation de la vitamine e en solution aqueuse Abandoned CA2088927A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2088927 CA2088927A1 (fr) 1993-02-11 1993-02-11 Mecanisme de conservation de la vitamine e en solution aqueuse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2088927 CA2088927A1 (fr) 1993-02-11 1993-02-11 Mecanisme de conservation de la vitamine e en solution aqueuse

Publications (1)

Publication Number Publication Date
CA2088927A1 true CA2088927A1 (fr) 1994-08-12

Family

ID=4151108

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2088927 Abandoned CA2088927A1 (fr) 1993-02-11 1993-02-11 Mecanisme de conservation de la vitamine e en solution aqueuse

Country Status (1)

Country Link
CA (1) CA2088927A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886030A (en) * 1994-05-06 1999-03-23 Alcon Laboratories, Inc. Use of vitamin E tocopheryl derivatives in ophthalmic compositions
WO2004095952A1 (fr) * 2003-04-29 2004-11-11 Eastman Chemical Company Boissons contenant de la vitamine e hydrosoluble
EP2722035B1 (fr) 2009-06-19 2016-04-27 Alcon Research, Ltd. Compositions pharmaceutiques aqueuses contenant des complexes de borate-polyol

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886030A (en) * 1994-05-06 1999-03-23 Alcon Laboratories, Inc. Use of vitamin E tocopheryl derivatives in ophthalmic compositions
WO2004095952A1 (fr) * 2003-04-29 2004-11-11 Eastman Chemical Company Boissons contenant de la vitamine e hydrosoluble
EP2722035B1 (fr) 2009-06-19 2016-04-27 Alcon Research, Ltd. Compositions pharmaceutiques aqueuses contenant des complexes de borate-polyol

Similar Documents

Publication Publication Date Title
Hamilton-Miller Antimicrobial properties of tea (Camellia sinensis L.)
Sforcin et al. Seasonal effect on Brazilian propolis antibacterial activity
BERGSSON et al. Killing of Gram‐positive cocci by fatty acids and monoglycerides Note
Conrad et al. Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro
Chambers et al. The osmoprotective properties of urine for bacteria: the protective effect of betaine and human urine against low pH and high concentrations of electrolytes, sugars, and urea
FI114852B (fi) Antimikrobisena aineena käytettävä hapotettu nitraatti
Wang et al. In vitro antibacterial activity and mechanism of monocaprylin against Escherichia coli and Staphylococcus aureus
KR20020069508A (ko) 사이프로플록사신 및 덱사메타손 함유 국소용 현탁제
Adebolu et al. Effect of garlic (Allium sativum) on Salmonella typhi infection, gastrointestinal flora and hematological parameters of albino rats
Oksuz et al. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits
DE69024784T2 (de) Mittel zur Verhütung von Infektionen mit Methicillin-beständigem Staphylococcus
CN100509027C (zh) 含有异丙醇、芝麻油、芦荟和柠檬油的无毒粘膜消毒剂
CN112245438B (zh) 一种抗细菌组合物及其复方马波沙星喷剂和制备方法
WO2013081331A1 (fr) Composition de préparation pour la peau pour une utilisation externe, ayant une excellente aptitude antiseptique
EP1863470B1 (fr) Procede de prevention et/ou de traitement d'infections vaginales et vulvaires
EP0264658A1 (fr) Composition stérilisante liquide
CA2088927A1 (fr) Mecanisme de conservation de la vitamine e en solution aqueuse
US9492489B2 (en) Uses of hibiscus, in particular pharmaceutical uses
Bowie et al. Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis
KR20030037094A (ko) 천연 항균 조성물
EP2575809B1 (fr) Compositions destinées à traiter une infection à helicobacter pylori
CN111328811B (zh) 一种低浓度酒精杀菌消毒液及其应用
CN113980889A (zh) 一种抗细胞内支原体感染的药物制剂及其用途
KANNAN et al. Treatment of experimental enzootic pneumonia of the pig by norfloxacin or its 6-chloro analogue
KR20050029649A (ko) 천연 항균 조성물

Legal Events

Date Code Title Description
FZDE Dead